Sheaff Brock Investment Advisors LLC Has $1.82 Million Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Sheaff Brock Investment Advisors LLC decreased its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 44,798 shares of the real estate investment trust’s stock after selling 773 shares during the period. Sheaff Brock Investment Advisors LLC’s holdings in Omega Healthcare Investors were worth $1,823,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Omega Healthcare Investors by 0.5% in the first quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust’s stock valued at $1,120,478,000 after acquiring an additional 165,105 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Omega Healthcare Investors by 7.9% during the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after purchasing an additional 272,299 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Omega Healthcare Investors by 4.6% during the second quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust’s stock worth $110,971,000 after purchasing an additional 143,521 shares during the last quarter. LSV Asset Management boosted its holdings in Omega Healthcare Investors by 0.7% in the second quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust’s stock valued at $67,411,000 after acquiring an additional 14,000 shares during the last quarter. Finally, Assetmark Inc. boosted its holdings in Omega Healthcare Investors by 1.7% during the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust’s stock worth $48,492,000 after buying an additional 19,542 shares during the last quarter. Institutional investors own 65.25% of the company’s stock.

Insider Buying and Selling

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.

Omega Healthcare Investors Price Performance

Shares of Omega Healthcare Investors stock opened at $39.97 on Friday. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The stock’s fifty day moving average is $40.66 and its 200 day moving average is $36.57. The stock has a market cap of $10.79 billion, a P/E ratio of 29.22, a P/E/G ratio of 1.25 and a beta of 0.99. Omega Healthcare Investors, Inc. has a one year low of $27.53 and a one year high of $44.42.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be given a dividend of $0.67 per share. The ex-dividend date of this dividend is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.71%. Omega Healthcare Investors’s payout ratio is 197.06%.

Analysts Set New Price Targets

OHI has been the topic of a number of recent research reports. Scotiabank lifted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th. Berenberg Bank assumed coverage on Omega Healthcare Investors in a report on Friday, October 18th. They set a “buy” rating and a $45.00 price target for the company. Truist Financial upped their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research report on Wednesday, September 4th. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price on the stock in a research report on Thursday, October 31st. Finally, Mizuho downgraded Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their price objective for the stock from $34.00 to $35.00 in a research note on Thursday, July 25th. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $40.00.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.